Moderna 2022 Priorities and Capital Allocation slide image

Moderna 2022 Priorities and Capital Allocation

People at high-risk who would benefit from annual boosting Slide 12 • Age over 50 • Health, age-related and environmental/occupation risk factors Age 18+ with other health risk factors, including: - - - Chronic kidney disease, chronic obstructive pulmonary disease, cardiac disease, and diabetes mellitus Receiving active cancer treatment for tumors or cancers of the blood Received an organ transplant and are taking medicine to suppress the immune system Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome) - Advanced or untreated HIV infection - Active treatment with high-dose corticosteroids or other drugs that may suppress their immune response Environmental/occupational risk factors: Healthcare workers - Police/fire department - High-density housing or living conditions (e.g. college students, military personnel, incarcerated individuals) https://www.cdc.gov/media/releases/2022/s0328-covid-19-boosters.html?s_cid=11706:covid%20vaccine%20booster:sem.ga:p:RG:GM:gen:PTN:FY22 https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by age.html#:~:text=Sample%20interpretation%3A%20Compared%20with%2018,year%2 Dold%20age%20category.) moderna
View entire presentation